Federal Trade Commission antitrust activities in the health care services field

Published date01 June 1984
DOI10.1177/0003603X8402900203
AuthorArthur N. Lerner
Date01 June 1984
Subject MatterArticle
The Antitrust Bulletin/Summer 1984
Federal Trade Commission
antitrust activities
in the health care services field
BYARTHUR N. LERNER*
205
Antitrust
litigation in
the
health care services field has exploded
in
the
last decade. This article surveys an
important
portion
of
that
growth,
government
antitrust
enforcement,
and
particularly
that
by
the
Federal
Trade
Commission.'
I.
Overview
of
the Commission's health care antitrust
program
In
the
first significant
antitrust
decisions in
the
health
care
services field,
both
the
Court
of
Appeals
for
the District
of
Assistant Director for Health Care, Bureau of Competition,
Federal Trade Commission.
AUTHOR'S NOTE: The views expressed in this article do not necessarily
reflect those
of
the Commission, any individual commissioner, or the
Bureau
of
Competition. The author acknowledges the assistance in
preparing this article provided by Oscar M.
Voss,
an attorney in the
Bureau
of
Competition.
1This article does not discuss the non-antitrust enforcement activi-
ties in the health care field of the Commission's Bureau of Consumer
Protection and regional offices. Furthermore, this article does not
discuss the merits of the legal analysis the Commission has applied in its
health care antitrust activities, or the appropriateness of applying
antitrust principles in health care markets. Rather, it provides a sum-
mary of the Commission's actions in the area, for those interested in
exploring the issues further.
©1984by Federal Legal Publications. Inc.
206 : The antitrust bulletin
Columbia
Circuit
and
the U.S. Supreme
Court
upheld a
jury's
conviction
of
the
American Medical Association (AMA)
and
a
local medical society for engaging in a criminal conspiracy to
obstruct
the
operation
of
aprepaid health care plan,
the
Group
Health
Association in Washington, D.C.2
The
court
of
appeals
found
that
the
AMA
was seeking in
part
to protect
"the
economic
status
of
the medical profession,")
but
the
court
emphasized
instead
another
theme, one
that
runs
through
antitrust theory: a
private
group
may
not
suppress competition simply because it
believes
that
doing so is in the public interest.
The
medical
societies claimed
that
boycotting the
group
health
plan
and
its
doctors
was justified because the plan was, in their view, illegal,
and
it was unethical for doctors to work for such aplan. In
rejecting this
argument,
the court explained
that
medical societies
are not law enforcement
agencies;
they are charged with no duties of
investigating or prosecuting, to say nothing of convicting and
punishing
....
Except for their size, their prestige and their
otherwise commendable activities, [defendants'] conduct in the pres-
ent case differs not at all from that of any other extra-governmental
agency which assumes power to challenge alleged wrongdoing by
taking the law into its own hands.'
Despite the success
of
this enforcement action against the
AMA,
antitrust
enforcement in
the
health services field was
limited until
the
mid-1970s because it was widely believed
that
enforcement
efforts
would be blocked by a variety
of
defenses,
such as the state
action,'
interstate commerce,"
and
McCar-
2American Medical Ass'n v. United States, 130 F.2d 233 (D.C.
Cir.
1942),
aff'd,
317 U.S. 519
(1943).
3130 F.2d at 239 n.23.
4[d. at 249.
5See Parker v. Brown, 317 U.S.
341
(1943).
6See, e.g., 15 U.S.C. §§ 1-3, 44,
45(a)(1)
(1976)
(jurisdiction
under Sherman and Federal Trade CommissionActs limitedto activities
with some nexus to interstate or international commerce, or commerce
in the District of Columbia).

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT